Change theme to redChange theme to blueChange theme to greenChoose your color

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


Processes and materials are provided for the detection, diagnosis, or determination of the severity of a neurological injury or condition, including traumatic brain injury, multiple-organ injury, stroke, Alzeimer's disease, Parkinson disease and Chronic Traumatic Encephalopathy (CTE). The processes and materials include biomarkers detected or measured in a biological sample such as whole blood, serum, plasma, or CSF. Such biomarkers include Tau and GFAP proteins, their proteolytic breakdown products, brain specific or enriched micro-RNA, and brain specific or enriched protein directed autoantibodies. The processes and materials are operable to detect the presence of absence of acute, subacute or chronic brain injuries and predict outcome for the brain injury.

Docket:WRAIR 17-09

Publication/Issued No.:10,041,959

Publication/Issue Date:2018-08-07

Categories: Assay,Diagnostic

More Detail:Visit USPTO.GOVExternal link


Inventor(s):WANG (DAVE), ET AL

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 28 Aug 2019

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736